- Home
- IPDN vs MIRA Comparison
IPDN vs MIRA Comparison
Compare IPDN & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- MIRA
- Stock Information
- Founded
- IPDN 2003
- MIRA 2020
- Country
- IPDN United States
- MIRA United States
- Employees
- IPDN N/A
- MIRA N/A
- Industry
- IPDN EDP Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- MIRA Health Care
- Exchange
- IPDN Nasdaq
- MIRA Nasdaq
- Market Cap
- IPDN 11.1M
- MIRA 17.1M
- IPO Year
- IPDN 2013
- MIRA 2023
- Fundamental
- Price
- IPDN $0.89
- MIRA $1.05
- Analyst Decision
- IPDN
- MIRA Strong Buy
- Analyst Count
- IPDN 0
- MIRA 2
- Target Price
- IPDN N/A
- MIRA $14.00
- AVG Volume (30 Days)
- IPDN 236.3K
- MIRA 552.1K
- Earning Date
- IPDN 11-12-2024
- MIRA 11-11-2024
- Dividend Yield
- IPDN N/A
- MIRA N/A
- EPS Growth
- IPDN N/A
- MIRA N/A
- EPS
- IPDN N/A
- MIRA N/A
- Revenue
- IPDN $7,319,905.00
- MIRA N/A
- Revenue This Year
- IPDN N/A
- MIRA N/A
- Revenue Next Year
- IPDN N/A
- MIRA N/A
- P/E Ratio
- IPDN N/A
- MIRA N/A
- Revenue Growth
- IPDN N/A
- MIRA N/A
- 52 Week Low
- IPDN $0.42
- MIRA $0.51
- 52 Week High
- IPDN $3.01
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- IPDN 59.33
- MIRA 38.97
- Support Level
- IPDN $0.77
- MIRA $1.04
- Resistance Level
- IPDN $0.97
- MIRA $1.20
- Average True Range (ATR)
- IPDN 0.14
- MIRA 0.07
- MACD
- IPDN -0.00
- MIRA 0.02
- Stochastic Oscillator
- IPDN 35.95
- MIRA 19.44
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.